Analysis of gene expression on a medium-or large-scale is an increasingly recognized method for functional and clinical investigations based on the now extensive catalog of known or partially sequenced genes. The accessibility of this approach can be enhanced by using readily available technology (macroarrays on Nylon, radioactive detection) and the IMAGE resource to assemble sets of targets. We have set up such a medium-scale,¯exible system and validated it by the study of quantitative expression levels for 120 genes in six cell lines, including three mammary carcinoma cell lines. A number of important parameters are identi®ed as necessary for the assembly of a valid set and the obtention of goodquality quantitative data. The extensive data assembled in this survey identi®ed potential targets of carcinogenesis, for example the CRABP2 and GATA3 transcription factor genes. We also demonstrate the feasibility of this procedure for relatively small tumor samples, without recourse to probe ampli®cation methods.
Recent studies have addressed the problem of alterations in human cancers in a global way, enumerating all genomic alterations, such as ampli®cations , translocations or deletions (Boige et al., 1997; Kerangueven et al., 1997; Mertens et al., 1997) , that may be present in a given type of human tumor. Global studies on the modi®cations that take place in human tumors at the level of transcription have also been undertaken. The Cancer Genome Anatomy Project (CGAP) analyses gene expression by constructing small cDNA libraries from microdissected tumors, tagsequencing the clones and scoring their number of occurrences in various tumors (Strausberg et al., 1997) .
Recently developed large-scale methods allow measurement of the expression levels for many genes simultaneously (for recent reviews see Jordan, 1998; Ramsay, 1998) . The most productive implementation uses hybridization of complex probes prepared from cell or tissue RNA to`macroarrays' of cDNA inserts on Nylon membranes (Bernard et al., 1996; Tsou et al., 1998) , miniaturized`microarrays' constructed on glass slides (Schena et al., 1995; DeRisi et al., 1996; Shalon et al., 1996) or on Nylon membranes (Chen et al., 1998) , or`DNA chips' carrying oligonucleotides (Lockhart et al., 1996; Wodicka et al., 1997) . In all cases, hybridization intensity can be used to derive expression data for each gene represented on the array. However, the miniaturized microarray and oligonucleotide chip technology is at this time relatively inaccessible to academic or clinical laboratories.
The approach using macroarrays in which PCR products from cDNAs are arranged on Nylon membranes and hybridized with radioactive probes (Nguyen et al., 1995; Bernard et al., 1996) is compatible with existing laboratory methods and equipment. A number of manufacturers have recognized this opportunity and provide ready-made macroarrays that can be quite useful. The approach is also very¯exible, allowing the individual laboratory to design and assemble custom sets adapted to each particular project using available IMAGE cDNA clones and relatively simple robotic equipment. Speci®c panels of genes can be designed to study human development, human diseases or to search for candidate disease genes or therapeutic target genes. In addition to their convenience, macroarrays also provide good sensitivity thanks to the large amount of target material that can be bound to Nylon (compared to a glass surface) and to the intrinsic sensitivity and dynamic range of radioactive detection.
However, obtaining valid, quantitative results from such studies requires attention to a number of parameters, from the de®nition and veri®cation of the clone set to the control of artefacts as well as the normalization, data handling and archiving procedures. We illustrate this with a survey of gene expression using a set of 120 genes, and monitoring of mRNA abundance for each of them in a set of six cell lines. We also show that this approach can be extended to tumor samples and only requires relatively small amounts of tissue to obtain quantitative data down to relative mRNA abundances approaching 1/50,000.
Membranes and obtention of hybridization signatures
We selected 128 genes known for their proven or putative implication in breast cancer and 65 genes implicated in immune reactions. They were represented by 194 cDNA clones (2 clones for the GAPDH gene) corresponding to the 3' end of the mRNA, and obtained through the IMAGE consortium. These Figure 1 Parameters, dynamic range and reproducibility of expression measurements. (a) Hybridization of an 8612 cm 2 membrane containing duplicate PCR-products of 166 clones and ®ve controls, hybridized with 1 mg g-33 P-ATP-labeled (Sambrook et al., 1989) vector oligonucleotide (5'-GGGAATTTGGCCCTCGAGGCCAA-3', located between the T7 primer and the insertion site of the vector and present in all PCR products) (left) and with a complex probe made from 25 mg of total RNA from the Kato III human gastric carcinoma cell line (right). Negative controls (poly(A) sequences and vector polylinker) are indicated at left. A few of the 2696 positive controls used for normalization are shown on both images (c554). At right, three sets of clones, corresponding to three dierent intensity levels, are pointed out. (b) Expression levels derived from this experiment after phosphor screen acquisition (FUJIX BAS 1500, Fuji), image analysis, vector oligonucleotide correction and normalization, expressed as percentage of abundance with respect to total RNA, for a set of 18 genes ranging from 1/50 000 to 3%. (c) Reproducibility of expression measurements displayed as a log/log diagram. Left, two twin membranes hybridized simultaneously with the same probe; right, the same membrane hybridized, stripped, and rehybridized with complex probes prepared from the same cell line. In both cases, the data were corrected for the amount of DNA in each spot as determined by vector oligonucleotide hybridization prior to complex probe hybridization. Details on genes, experimental procedures and data handling can be found in Nguyen et al. (1995) , Bernard et al. (1996) , Granjeaud et al. (1996) , Rocha et al. (1997) , and on our web site http: //tagc.univ-mrs.fr/pub/Cancer/ Figure 2 Dierential gene expression between two samples. (a) Top: membrane images after hybridization with complex probes made from total RNA from MDA-MB-134 mammary carcinoma (left) and Kato III gastric carcinoma (right) cell lines. Some housekeeping (GAPDH, Actin), and dierentially expressed (GATA3, FGFR1, FGFR2, GSTp, CRABP2, SOX9) genes are highlighted. Bottom: comparison of quanti®ed and normalized mRNA levels for these two cell lines displayed as a log/log diagram. High dierential expression is observed for a number of genes. (b) Top: membrane images after hybridization with complex probes made from total RNA (5 mg) from mammary carcinoma samples T7409 and T7432. Bottom: comparison of quanti®ed and normalized expression levels displayed as a log/log diagram. The majority of expression levels remain similar within a factor of two, although some dierential expression is obvious. Details on experimental procedures and data can be found on our web site: http://tagc.univ-mrs.fr/pub/Cancer/ Figure 3 Dierential gene expression between six human cancer cell lines. Membranes were successively hybridized with complex probes made from total RNA from the HBL100 immortalized mammary cell line, the BT474, MCF7 and MDA-MB-134 mammary carcinoma cell lines, the Kato III gastric carcinoma cell line and the Yusit-1 melanoma cell line. Quanti®ed hybridization signals (obtained by image clones were chosen using the EST database (dbEST release 091495) from the National Center for Biotechnology Information (Bethesda, MD, USA) via the World Wide Web (http://www.ncbi.nlm.nih.gov). The clones were selected from libraries constructed by B Soares and had to ful®ll certain criteria: same cloning vector (pT7T3D) with a modi®ed polylinker, same host bacteria (E. coli DH10B), homogeneous insert size (near 1 kb) and absence of detectable repeat sequences according to the EST data available. All clones were provided by the Human Genome Mapping Project Resource Centre (Hinxton, UK). Five control clones were included: three poly(A) sequences, pT7T3D, and a plant gene (see below). They were transferred into pT7T3D to assemble a coherent set of clones in the same plasmid vector and bacterium.
The 199 cDNA clones were ampli®ed in four 96-well microtiter plates using a vector-PCR ampli®cation with T7 (5'-ATTATGCTGAGTGATATCCCT-3') and T3 (5'-TCCCTTTAGTGAGGGTTAAT-3') primers. The fourth plate contained the PCR products of the A. Thaliana cytochrome c554 gene in all wells. The identity of the IMAGE clones was ®rst deduced from the size of the PCR products measured on the agarose gel electrophoresis and comparison with the size recorded in dbEST. The initial group was reduced to 171 (including the ®ve control clones) after failure of PCR ampli®cation (no PCR product or PCR product with more than one band or with an unexpected size) for 28 members. The concentration of the ampli®ed product was adjusted to 0.6 pmol ml 71 . The PCR products were spotted in duplicate on membranes. The quanti®cation of the hybridization signals after vector hybridization allowed estimation of the amount of DNA accessible to the probe contained in each spot. Then, the membranes were stripped and hybridized with a complex probe made from total RNA from human tumor cells (the list of clones and details on the preparation of the membranes and probes can be found on our web site: http://tagc.univ-mrs.fr/pub/ Cancer/).
All membranes contained a set of control spots made of three dierent entities (Figure 1a) . The pT7T3D vector and poly(A) sequences (C3: 50-bp long, A10: 60-bp long, E6: 90-bp long) were used as negative controls; their signal determined the level of membrane background and checked for the elimination of spurious hybridization via the poly(A) tail present in some clones (Gress et al., 1992; Nguyen et al., 1995) . We used a large excess (8 mg) of oligo(dT) primers (dT25) during the preparation of the complex probe and, at the end of the procedure, performed annealing of the labeled probe with poly(dA80). This, together with stringent hybridization and washing conditions, allowed the elimination of this eect. The third type of control, the Arabidopsis thaliana cytochrome c554 clone, has no similarity with human DNA sequences (Bernard et al., 1996) . Its spotting onto membranes and the inclusion of a known amount (1 ng) of in vitro synthesized c554 mRNA in the complex probe, allowed the values of each independent hybridization to be normalized, making up for dierences in labeling, washing, duration of exposure and progressive degradation of the membranes. Thus, the dierential expression levels for each clone could be compared with con®dence.
With a complex probe such as the one prepared from Kato III RNA (Figure 1a) , signals displayed a wide range of intensities after quanti®cation and normalization. Negative control clones gave no signal, indicating the absence of non-speci®c hybridization. Nearly 20% of the cDNAs gave no detectable signal. Among the positive signals, the intensity values were highly variable, ranging over three to four orders of magnitude. The average background level corresponded to the signal intensity observed for a gene expressed at an abundance of 0.01%, and this background ®gure had a standard deviation of 10% (i.e. 0.001% when expressed as a mRNA abundance value). Results for 18 clones are also represented in graphic form in Figure 1b , ordered by increasing intensity on a logarithmic scale, and expressed as per cent abundance relative to total cellular mRNA, using for this normalization the signal measured for c554 mRNA added at 0.2% abundance in the complex probe (Bernard et al., 1996; Rocha et al., 1997) .
Reproducibility of hybridizations
To verify the reproducibility of complex probe hybridizations, dierent measurements were done. Firstly, we analysed the variation between the duplicate spotted dots, since the resulting normalized data was the mean of their two corresponding intensities. For each one of the six complex probes made from cell line mRNA, 97 ± 98% of the clones showed less than a twofold dierence in signal intensity; the remaining 2 ± 3% showed a 2 ± 4-fold dierence.
Secondly, we assessed the reproducibility of the hybridizations by analysing dierent membranes, and dierent probes made from the same batch of total RNA. We ®rst compared the signal intensities for twin membranes hybridized with the same complex probe. The signal intensities for all spots on one membrane were plotted against those from the other membrane. All the values were clustered along a diagonal, suggesting good reproducibility (Figure 1c, left) . We next tested the reproducibility between two independent hybridizations of the same membrane with complex probes. A membrane was hybridized with a complex probe and after exposure and quanti®cation, it was stripped and rehybridized with a new probe made from the same batch of total RNA (Figure 1c,  right) . The signal intensities of all clones of the ®rst hybridization plotted against those of the second analysis (using the HDG Analyser software, Genomic Solutions, USA) of imaging plate data acquired with a FUJIX BAS 1500 machine were normalized as previously described (Rocha et al., 1997) . The resulting normalized data could be compared between dierent clones on the same and on dierent membranes during the same and independent hybridizations. They were then analysed using Excel software (Microsoft). Quanti®ed and normalized hybridization intensities of the 125 analysed clones were expressed as percentage of abundance of individual mRNA within the sample. Results are represented using a gray color ladder (the actual quantitative results are available on our web site: http://tagc.univ-mrs.fr/pub/Cancer/) hybridization showed a distribution of the values along a diagonal, suggesting satisfactory reproducibility.
Thirdly, we tested the reproducibility between hybridizations done with complex probes made from two dierent batches of the same total RNA extracted at dierent times with the same method (Trizol reagent ± GIBCO BRL). We did this experiment for the six cell lines (not shown). Ninety per cent of the clones gave expression values that did not dier by more than twofold (96% within threefold). These reproducibility data indicate the con®dence limits, validate the technical approach and justify its use for quantitative expression measurement.
Obtention of the ®nal clone set designed for hybridization analysis
It was paramount to identify spotted clones containing repeat sequences which may result in spurious signals, and to exclude them from further analysis. These clones were identi®ed by a preliminary hybridization with 50 ng of Cot1 DNA labeled by 33 P-random priming at 500 000 c.p.m./ml overnight. Twenty-nine clones among the 171 spotted on membranes gave a strong signal (see our web site).
The remaining 142 clones had no Cot1 signal. They were further checked by 5' tag-sequencing to assess their identity. Sequencing failed for eight clones. A total of 134 had a sequence that could be compared with data present in dbEST and other databases. Among these, nine did not correspond to the expected clone, indicating an aggregate error rate (originating from the primary IMAGE collection and possibly from the distribution process) of 6.5%. The remaining 125 cDNAs (including the ®ve controls) corresponded to the expected clones and genes, and thus, represented the ®nal clone set for complex probe hybridization analyses.
Dierential gene expression between cancer cells
Membranes were hybridized successively with complex probes made from cell lines: three mammary carcinoma cell lines, BT474, MCF7 and MDA-MB-134, the HBL100 line which is derived from the immortalization of normal breast tissue, Kato III, a gastric carcinoma cell line and Yusit-1, a melanoma cell line (a kind gift from R Halaban, Yale University). The latter two were included to give an idea of dierences that re¯ect tissue speci®c expression.
Examples of results are shown in Figure 2 and comprehensive results on the six cell lines are shown in Figure 3 . Forty of the 120 genes analysed displayed zero or very low (50.01%) expression levels in all six cell lines. Thus, a fair percentage of genes may not be useful to discriminate between dierent cancer cells, including those originating from distinct types of tissue. Two clones, GAPDH and g Actin, initially chosen as controls of ubiquitous expression, were, as expected, highly expressed in all six cell lines.
For other clones, a dierential expression pro®le was found. For example, as shown in Figure 2a (bottom) , the graphical comparison between MDA-MB-134 and Kato III showed that, while the majority of genes were expressed with approximatively the same intensity in both cell lines, some were speci®cally expressed (SOX9, GSTp) or overexpressed (FGFR2) in Kato III, and, reciprocally, others were speci®cally expressed (GATA3) or overexpressed (FGFR1, CRABP2) in MDA-MB-134. In agreement with our previous expression analyses (Theillet et al., 1993; PenaultLlorca et al., 1994 PenaultLlorca et al., , 1995 , FGFR1, FGFR2 (Figures  2a and 3 ) and ERBB2 (data not shown) were highly expressed in MDA-MB-134, Kato III and BT474, respectively.
Overall, clones representative of transcription factors were often expressed at detectable levels and some had a clear dierential pattern (Figure 3 ). This may re¯ect the fact that the function of transcription factor genes is strongly regulated at the transcription level while this control is less predominant for other types of molecules. Important work on knock-out mice has shown that several transcription factors, beside hormone receptors, are essential to mammary gland development (reviewed in Hennighausen and Robinson, 1998) . Some transcription factors, such as CRABP2 or GATA3, had a clear dierential pattern between HBL100 and the breast carcinoma cell lines. CRABP2 is a regulator of retinoic acid signaling in breast cancer cells. The two SOX genes of the array displayed dierential expression between the cell lines. It is tempting to attribute this to their possible involvement in FGFR pathways, which, as a result of the ampli®cation and overexpression of the FGFR genes, are overabundant in MDA-MB-134 and Kato III. Indeed, SOX and FGF appear to share some functions (Yuan et al., 1995; Winter, 1995) . The same may be true for GATA3 and CRABP2 although less information is available.
This analysis allowed us to validate our method on readily available and homogeneous material. The same approach was then tested on fresh breast tumor samples. Two surgically removed breast tumor samples (T7409 and T7432) were randomly chosen from our tumor panel, and complex probes were prepared from small aliquots (5 mg) of total RNA. As shown in Figure 2b , the quality of the hybridizations was equivalent to those previously obtained with the cell lines: the background level was low, the poly(A) and pT7T3D clones did not give any signal, the ubiquitously expressed genes (GAPDH and g Actin) had a strong signal. The intensity values showed a high variability between the dierent clones with a range over three to four orders of magnitude. Dierential gene expression was detectable between tumors ( Figure  2b) , and between tumors and cell lines (not shown). The comparison between the two tumor samples showed that 20% of genes had a dierential expression with a factor above twofold. Some of them, such as GSTp or Mucin1, showed a factor greater than six. The comparison between data from breast cancer cell lines and those from breast cancer tissues revealed a similar extent of dierential expression.
Conclusion
Our study on the expression of a number of cDNA clones in a set of human tumor cell lines was designed to determine the best parameters for a method of expression pro®ling that may be used in further studies on tumor samples from patients.
The choice of the genes to be included is dependent not only on their involvement in the biological process being studied, but must also take into account their expression level: if pro®ling is done under conditions providing a lower detection limit of 1/50 000, genes that are usually expressed much below these levels are unlikely to be informative. This information is usually not available in the literature, and for us this resulted in about 30% of the selected genes being expressed at zero or very low levels in all six cell lines tested. Once the set of genes is de®ned, the corresponding IMAGE cDNA clones must be selected and obtained. From our experience, the cumulative error rate originating from the source, the sequencing operation or the distributor can approach 10%. Tag resequencing (or purchase of previously resequenced clones) is a regrettable but unavoidable necessity. The clones must also be checked for the possible presence of repeat sequences.
Expression values obtained using DNA array hybridization are quantitative providing the experiments are done in a highly controlled way, as shown by ourselves (Nguyen et al., 1995; Bernard et al., 1996) and by others using dierent implementations of this method (Schena et al., 1995; Lockhart et al, 1996) . This involves two distinct aspects: hybridization conditions ensuring large target excess, linear hybridization kinetics and uniform reaction rates across the array on the one hand, and detection methods providing linearity over a wide range on the other hand. In this respect, radioactive methods have the advantage of allowing an essentially in®nite intrinsic dynamic range, while imaging plate detection displays linearity over at least four decades. Comparison with direct detection devices (Bertucci et al., in preparation) veri®es this in the experimental conditions used. The`vertical normalization' done using control target DNAs allows comparison between dierent experiments and relates the signals measured to mRNA abundance. This involves some assumptions (e.g. considering that mRNA represents 2% of total RNA mass), that in¯uence the scaling of the values obtained, but allows presentation of results in an informative and generally useful fashion. The internal consistency of our results is very adequate, as demonstrated by the reproducibility experiments shown in Figure 1 and also by the consistent levels obtained for genes expected to display similar expression in all tissues (Figure 3 , see detailed results on our web site).
These data show the capacity of the method for de®ning the expression pro®les of human cancers starting from the RNA extracted from the corresponding tissues, even if the amount of RNA is low. It is important at this point to keep in mind that published expression pro®ling work with microarrays or oligonucleotide chips uses microgram amounts of poly(A) + RNA for probe preparation (Schena et al., 1996; Lockhart et al., 1996) , or resorts to probe ampli®cation methods that may skew relative abundance values. Further miniaturization using Nylon microarrays (Chen et al., 1998) and radioactive probes (with a very high-resolution detection system) can bring down sample requirements by a large factor (Bertucci et al., in preparation), but in the implementation described here, the method is already able to provide signi®cant information in clinically relevant situations.
